Adenovirus-mediated fibroblast growth factor 1 expression in the lung induces epithelial cell proliferation: Consequences to hyperoxic lung injury in rats

Human Gene Therapy

Volumn 15, Issue 8, 2004, Pages 793-804

  Louzier, Vanessa ^a   Raoul, William ^a   Leroux, Aude ^b   Branellec, Didier ^b   Caillaud, Jean Michel ^b   Many, Hélène ^a   Levame, Micheline ^a   Delclaux, Christophe ^a   Adnot, Serge ^a   Maitre, Bernard ^a,c  

^a HENRI MONDOR HOSPITAL   (France)

^b Cardiovasc Gene Therapy Department   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; FIBROBLAST GROWTH FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRONCHUS MUCOSA; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; GENE EXPRESSION; HISTOPATHOLOGY; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM; LUNG LAVAGE; LUNG TOXICITY; NONHUMAN; OXYGEN TOXICITY; PROTEIN BLOOD LEVEL; RAT; TREATMENT OUTCOME; VIRAL GENE THERAPY; VIRUS LOAD; VIRUS PARTICLE;

ADENOVIRIDAE; ANIMALIA; BRONCHUS; RATTUS NORVEGICUS;

EID: 4143114677     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/1043034041648390     Document Type: Article

References (40)

1. BARAZZONE, C., DONATI, Y.R., ROCHAT, A.F., VESIN, C., KAN, C.D., PACHE, J.C., and PIGUET, P.F. (1999). Keratinocyte growth factor protects alveolar epithelium and endothelium from oxygen-induced injury in mice. Am. J. Pathol. 154, 1479-1487.
2. BARDALES, R.H., XIE, S.S., SCHAEFER, R.F., and HSU, S.M. (1996). Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am. J. Pathol. 149, 845-852.
3. BLANCHE, F., CAMERON, B., BARBOT, A., FERRERO, L., GUILLEMIN, T., GUYOT, S., SOMARRIBA, S., and BISCH, D. (2000). An improved anion-exchange HPLC method for the detection and purification of adenoviral particles. Gene Ther. 7, 1055-1062.
4. BRODY, S., METZGER, M., DANEL, C., ROZENFELD, M., and CRYSTAL, R. (1994). Acute response of non-human primates to airway delivery of an adenovirus vector containing the human CFTR cDNA. Hum. Gene Ther. 5, 821-836.
5. BUCKLEY, S., BARSKY, L., DRISCOLL, B., WEINBERG, K., ANDERSON, K.D., and WARBURTON, D. (1998). Apoptosis and DNA damage in type 2 alveolar epithelial cells cultured from hyperoxic rats. Am. J. Physiol. 274, L714-L720.
6. BURGESS, W.H., MEHLMAN, T., MARSHAK, D.R., FRASER, B.A., and MACIAG, T. (1986). Structural evidence that endothelial cell growth factor β is the precursor of both endothelial cell growth factor and acidic fibroblast growth factor. Proc. Natl. Acad. Sci. U.S.A. 83, 7216-7220.
7. CANADA, A.T., HERMAN, L.A., and YOUNG, S.L. (1995). An age-related difference in hyperoxia lethality: Role of lung antioxidant defense mechanisms. Am. J. Physiol. 268, L539-L545.
8. COZENS, A., YEZZI, M., YAMAYA, M., STEIGER, D., WAGNER, J., GARBER, S., CHIN, L., SIMON, E., and GRUENERT, D. (1992) A transformed human epithelial cell line that retains tight junctions post crisis. In Vitro Cell. Dev. Biol. 28A, 735-744.
9. CRAPO, J.D. (1986). Morphologic changes in pulmonary oxygen toxicity. Annu. Rev. Physiol. 48, 721-731.
10. CROUZET, J., NAUDIN, L., ORSINI, C., VIGNE, E., FERRERO, L., LE ROUX, A., BENOIT, P., LATTA, M., TORRENT, C., BRANELLEC, D., DENEFLE, P., MAYAUX, J.F., PERRICAUDET, M., and YEH, P. (1997). Recombinational construction in Escherichia coli of infectious adenoviral genomes. Proc. Natl. Acad. Sci. U.S.A. 94, 1414-1419.
11. DRISKELL, R.A., and ENGELHARDT, J.F. (2003) Current status of gene therapy for inherited lung disease. Annu. Rev. Physiol. 65, 585-612.
12. FACTOR, P., MENDEZ, M., MUTLU, G.M., and DUMASIUS, V. (2002) Acute lung injury does not impede adenoviral-mediated alveolar gene transfer. Am. J. Respir. Crit. Care Med. 165, 521-526.
13. FEHRENBACH, H., KASPER, M., KOSLOWSKI, R., PAN, T., SCHUH, D., MULLER, M., and MASON, R.J. (2000). Alveolar epithelial type II cell apoptosis in vivo during resolution of keratinocyte growth factor-induced hyperplasia in the rat. Histochem. Cell Biol. 114, 49-61.
14. FRANEK, W.R., HOROWITZ, S., STANSBERRY, L., KAZZAZ, J.A., KOO, H.C., LI, Y., ARITA, Y., DAVIS, J.M., MANTELL, A.S., SCOTT, W., and MANTELL, L.L. (2001). Hyperoxia inhibits oxidant-induced apoptosis in lung epithelial cells. J. Biol. Chem. 276, 569-575.
15. FRANK, L., BUCHER, J.R., and ROBERTS, R.J. (1978). Oxygen toxicity in neonatal and adult animals of various species. J. Appl. Physiol. 45, 699-704.
16. GAVRIELI, Y., SHERMAN, Y., and BEN-SASSON, S.A. (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493-501.
17. GOULD, V.E., TOSCO, R., WHEELIS, R.F., GOULD, N.S., and KAPANCI, Y. (1972). Oxygen pneumonitis in man: Ultrastructural observations on the development of alveolar lesions. Lab. Invest. 26, 499-508.
18. GUO, J., YI, E.S., HAVILL, A.M., SAROSI, I., WHITCOMB, L., YIN, S., MIDDLETON, S.C., PIGUET, P., and ULICH, T.R. (1998). Intravenous keratinocyte growth factor protects against experimental pulmonary injury. Am. J. Physiol. 275, L800-L805.
19. HARRIS, J.B., CHANG, L.Y., and CRAPO, J.D. (1991). Rat lung alveolar type I epithelial cell injury and response to hyperoxia. Am. J. Respir. Cell Mol. Biol. 4, 115-125.
20. HARVEY, B.C., MARONI, J., O'DONOGHUE, K.A., CHU, K.W., MUSCAT, J.C., PIPPO, A.L., WRIGHT C.E., HOLLMANN, C., WISNIVESKY, J.P., KESSLER, P.D., RASMUSSEN, H.S., ROSENGART, T.K., and CRYSTAL, R.G. (2002). Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions. Hum. Gene Ther. 13, 15-63.
21. HOKUTO, I., PERL, A.K.T., and WHITSETT, J.E. (2004) FGF signaling is required for pulmonary homeostasis following hyperoxia. Am. J. Physiol. 286, L580-L587.
22. JOUANNEAU, J., GAVRILOVIC, J., CARUELLE, D., JAYE, M., MOENS, G., CARUELLE, J.P., and THIERY, J.P. (1991). Secreted or nonsecreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility, and invasive potential. Proc. Natl. Acad. Sci. U.S.A. 88, 2893-2897.
23. KAPANCI, Y., WEIBEL, E.R., KAPLAN, H.P., and ROBINSON, F.R. (1969). Pathogenesis and reversibility of the pulmonary lesions of oxygen toxicity in monkeys. II. Ultrastructural and morphometric studies. Lab. Invest. 20, 101-118.
24. KIM, I., MOON, S., YU, K., KIM, U., and KOH, G.Y. (2001). A novel fibroblast growth factor receptor-5 preferentially expressed in the pancreas. Biochim. Biophys. Acta 1518, 152-156.
25. KISTLER, G.S., CALDWELL, P.R., and WEIBEL, E.R. (1967). Development of fine structural damage to alveolar and capillary lining cells in oxygen-poisoned rat lungs. J. Cell Biol. 32, 605-628.
26. LESLIE, C.C., MCCORMICK-SHANNON, K., ROBINSON, P.C., and MASON, R.J. (1985). Stimulation of DNA synthesis in cultured rat alveolar type II cells. Exp. Lung Res. 8, 53-66.
27. LESLIE, C.C., MCCORMICK-SHANNON, K., and MASON, R.J. (1990). Heparin-binding growth factors stimulate DNA synthesis in rat alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 2, 99-106.
28. LESLIE, C.C., MCCORMICK-SHANNON, K., SHANNON, J.M., GARRICK, B., DAMM, D., ABRAHAM, J.A., and MASON, R.J. (1997). Heparin-binding EGF-like growth factor is a mitogen for rat alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 16, 379-387.
29. PANOS, R.J., RUBIN, J.S., CSAKY, K.G., AARONSON, S.A., and MASON, R.J. (1993). Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium. J. Clin. Invest. 92, 969-977.
30. PANOS, R.J., BAK, P.M., SIMONET, W.S., RUBIN, J.S., and SMITH, L.J. (1995). Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats. J. Clin. Invest. 96, 2026-2033.
31. RAY, P., DEVAUX, Y., STOLZ, D.B., YARLAGADA, M., WATKINS, S.C., YUNBIAO, L., CHEN, L., YANG, X.F., and RAY, A. (2002) Inducible expression of keratinocyte growth factor (GKGF) in mice inhibits lung epithelial cell death induced by hyperoxia. Proc. Natl. Acad. Sci. U.S.A. 100, 6098-6103.
32. SANNES, P.L., BURCH, K.K., and KHOSLA, J. (1992). Immunohistochemical localization of epidermal growth factor and acidic and basic fibroblast growth factors in postnatal developing and adult rat lungs. Am. J. Respir. Cell Mol. Biol. 7, 230-237.
33. SARIA, A., and LUNDBERG, J.M. (1983). Evans blue fluorescence: Quantitative and morphological evaluation of vascular permeability in animal tissues. J. Neurosci. Methods 8, 41-49.
34. SLEEMAN, M., FRASER, J., MCDONALD, M., YUAN, S., WHITE, D., GRANDISON, P., KUMBLE, K., WATSON, J.D., and MURISON, J.G. (2001). Identification of a new fibroblast growth factor receptor, FGFR5. Gene 271, 171-182.
35. STAUB, N.C. (1974). Pulmonary edema. Physiol. Rev. 54, 678-811.
36. THET, L.A., PARRA, S.C., and SHELBURNE, J.D. (1986). Sequential changes in lung morphology during the repair of acute oxygen-induced lung injury in adult rats. Exp. Lung Res. 11, 209-228.
37. UHAL, B.D., JOSHI, I., HUGHES, W.F., RAMOS, C., PARDO, A., and SELMAN, M. (1998). Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am. J. Physiol. 275, L1192-L1199.
38. ULICH, T.R., YI, E.S., LONGMUIR, K., YIN, S., BILTZ, R., MORRIS, C.F., HOUSLEY, R.M., and PIERCE, G.F. (1994). Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo. J. Clin. Invest. 93, 1298-1306.
39. WITSCHI, H. (1990). Responses of the lung to toxic injury. Environ. Health Perspect. 85, 5-13.
40. 2 exposure. Am. J. Physiol. 275, L780-L787.